Roche’s Gazyva Gains FDA Approval for Lupus Nephritis Treatment
A new treatment option for lupus nephritis has emerged with the FDA’s recent approval of Roche’s drug, Gazyva. This biologic therapy, previously established as a cancer treatment, is now authorized…